Myeloma Foundation Uses Patient Connections To Help Speed Drug Trials
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Bolstered by a huge patient database, the Multiple Myeloma Research Consortium is helping to speed trials of new therapies, including some of the most talked about investigational drugs in the disease space, like carfilzomib and pomalidomide.